학술논문
Phase I biomarker analysis of farletuzumab ecteribulin (FZEC), formerly MORAb-202, effects on cancer responses in patients with platinum resistant ovarian cance
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15388514